AviSia Therapeutics is a clinical-stage biotechnology company headquartered in Amsterdam, Netherlands, pioneering antigen-specific immunotherapies for autoimmune diseases.…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see AviSia Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks AviSia Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.